Significant Ownership of Srinivas Akkaraju

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Srinivas Akkaraju focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 1 identity field
Manager location
Palo Alto, CA

Follow Filing Activity

Follow Srinivas Akkaraju with Pro and return when a new Schedule 13D/G filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Significant Ownership of Srinivas Akkaraju

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KLRS KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 54% $85,014,842 -$349,257 12,900,583 -0.41% Srinivas Akkaraju 20 May 2026
VTVT VTV THERAPEUTICS INC. Class A Common Stock, par value $0.01 per share 9.9% $12,001,117 +$1,803,961 403,942 +18% Srinivas Akkaraju 08 Dec 2025
RANI RANI THERAPEUTICS HOLDINGS, INC. Class A Common Stock, $0.0001 par value per share 9.9% $10,417,124 +$1,325,245 11,322,961 +15% Srinivas Akkaraju 26 May 2026
MLYS MINERALYS THERAPEUTICS, INC. Common Stock 8.2% $85,419,771 +$8,209,106 6,346,194 +11% Srinivas Akkaraju 04 Sep 2025
IVA Inventiva S.A. Ordinary shares, nominal value (euro) 0.01 per share 7.4% $56,191,805 +$22,319,746 13,540,194 +66% Srinivas Akkaraju 17 Nov 2025
SRRK SCHOLAR ROCK HOLDING CORP Common Stock, par value $0.001 per share 7.2% $260,368,230 6,991,553 Srinivas Akkaraju 03 Oct 2025
ALMS ALUMIS INC. Common Stock, $0.0001 par value per share 5.4% $61,929,972 +$11,811,946 6,345,219 +24% Srinivas Akkaraju 09 Jan 2026

Schedules 13D/G Reported by Srinivas Akkaraju:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .